United Therapeutics

United Therapeutics

Yahoo Finance • 7 days ago

Biotech Options Buzz: UTHR, NMRA, EWTX

Biotech stocks are dominating today's unusual options volume list, with United Therapeutics Corporation (NASDAQ: UTHR), Neumora Therapeutics Inc (NASDAQ: NMRA), and Edgewise Therapeutics Inc (NASDAQ: EWTX) all attracting outsized attention... Full story

Yahoo Finance • 14 days ago

Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?

It has been about a month since the last earnings report for Altimmune, Inc. (ALT). Shares have added about 14.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings relea... Full story

Yahoo Finance • 18 days ago

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

Company Logo Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The pulmonary arterial hyperten... Full story

Yahoo Finance • 23 days ago

3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We're Skeptical Of Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tomorrow. Not all... Full story

Yahoo Finance • 24 days ago

Ten healthcare stocks leading in year-over-year CapEx growth

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images With the second-quarter earnings season now largely behind us, investors are turning their attention to how healthca... Full story

Yahoo Finance • 24 days ago

Top Research Reports for Toyota Motor, CrowdStrike & Welltower

Tuesday, September 1, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), CrowdStrike Holdings,... Full story

Yahoo Finance • 26 days ago

United Therapeutics highlights new data supporting two FDA filings

[Headquarters of US Food and Drug Administration (FDA)] Grandbrothers/iStock Editorial via Getty Images United Therapeutics (UTHR [https://seekingalpha.com/symbol/UTHR]) is presenting new analyses of ralinepag and inhaled treprostinil at... Full story

Yahoo Finance • last month

Will LQDA's Differentiated PAH Approach Drive Growth?

Liquidia Corporation LQDA is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (P... Full story

Yahoo Finance • last month

United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis

Approximately 200,000 patients in the United States have PPF, with limited treatment options Topline data expected in the second half of 2027 SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., August 17, 2026--(BUSINESS WIRE)--United The... Full story

Yahoo Finance • last month

BETA Technologies Inc (BETA) (Q2 2026) Earnings Call Highlights: Revenue Surges 146% as ...

This article first appeared on GuruFocus. Release Date: August 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revenue in Q2 2026 was $14.7 million, exceedin... Full story

Yahoo Finance • 2 months ago

United Therapeutics' Q2 Tyvaso Miss Reflects Competition; IPF Outreach Set to Expand, Morgan Stanley Says

United Therapeutics' (UTHR) Q2 miss for Tyvaso reflected pressure from rising competition, though th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

Investors choosing between Simplify Health Care ETF (NYSEMKT:PINK) and State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) may weigh the SPDR fund's significantly lower costs against the Simplify fund's active management and char... Full story

Yahoo Finance • 2 months ago

United Therapeutics Appoints Victor Dzau To Board Of Directors

(RTTNews) - United Therapeutics Corporation (UTHR), announced on Thursday the appointment of Victor Dzau to its Board, effective immediately. Dzau recently completed a 12-year term as President at the National Academy of Medicine and curr... Full story

Yahoo Finance • 2 months ago

Liquidia jumps as judge criticizes United Therapeutics in patent dispute

[Judge Gavel Beside Open Law Book With Turning Pages] jittawit.21/iStock via Getty Images Liquidia Corp. (LQDA [https://seekingalpha.com/symbol/LQDA]) rose 8% after a judge in a long-standing patent dispute with United Therapeutics (UTHR... Full story

Yahoo Finance • 2 months ago

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

Investors comparing these two funds are really choosing between two different philosophies. The iShares Global Healthcare ETF (NYSEMKT:IXJ) is a low-cost, diversified way to own the global healthcare sector. The Simplify Health Care ETF (N... Full story

Yahoo Finance • 2 months ago

Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1

Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1 Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at Gil... Full story

Yahoo Finance • 2 months ago

Here’s Laughing Water Capital’s Updates on Liquidia Corp. (LQDA)

Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The second quarter was exceptionally good for the portfolio, with Class A investment i... Full story

Yahoo Finance • 2 months ago

Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market?

Liquidia Corporation LQDA is banking on lead drug's Yutrepia's ability to sustain its strong commercial momentum despite intense competition in the pulmonary arterial hypertension (PAH) market. The drug is an inhaled dry-powder version of... Full story

Yahoo Finance • 3 months ago

Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at AbbVie (NYSE:ABBV) and its p... Full story

Yahoo Finance • 3 months ago

United Therapeutics buys Thymmune Therapeutics

* United Therapeutics (UTHR [https://seekingalpha.com/symbol/UTHR]) said it acquired [https://seekingalpha.com/pr/20571167-united-therapeutics-corporation-acquires-thymmune-therapeutics] privately held preclinical biotech Thymmune Therap... Full story